Max Bayer - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Max Bayer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Max Bayer

Max Bayer

Verified

Reporter, Endpoints News

New York

Final Covers

Social justice healthcare leadership ethical business

Doesn’t Cover

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 1235

  • CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s

    By Max Bayer Verified

    Apr. 16, 2025

  • CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

    By Max Bayer Verified

    Apr. 17, 2025

  • CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

    By Max Bayer Verified

    Apr. 17, 2025

As seen in

Company Info

Endpoints News

Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.

Lawrence, Kansas, United States

+1 785-813-1733

Founded: 2014